Shillitoe E J, Silverman S
Oral Surg Oral Med Oral Pathol. 1979 Sep;48(3):216-24. doi: 10.1016/0030-4220(79)90006-9.
Numerous studies have suggested that patients with oral cancer have an increased immune response to herpes simplex virus. However, the number of cases has always been small, and essential controls have not always been included. Laboratory experiments have shown that herpes simplex virus can be carcinogenic or cocarcinogenic under certain circumstances and so must be considered as a possible etiologic agent in oral cancer. This article reviews past research and suggests priorities for future investigations.
